user avatar
Journal of Clinical Oncology
@JCO_ASCO
@ASCO's credible, authoritative resource for disseminating clinical oncology research. Home of @JCOOP_ASCO, @JCOGO_ASCO, @JCOCCI_ASCO, @JCOPO_ASCO, @JCOOA_ASCO.
Joined March 2014
Posts
  • Pinned
    user avatar
    Celebrating 40 years of pioneering oncology research with @ASCO's Journal of Clinical Oncology! We're thrilled to share this milestone in our history. Look forward to the reveal of our most-cited publication on 12/15. Discover the top-cited articles: [ascopubs.org/jco/40th-anniv…]
    00:00
  • user avatar
    🙌 Enfortumab vedotin + pembro as 1st-line tx for metastatic #UrothelialCancer yields response rate of 73.3%, duration of response 25.6 mo, overall survival 26.1 mo. 👉 fal.cn/3sEjU #JCO #blcsm #kcsm #gucsm @DrRosenbergMSK
  • user avatar
    ‼️ #JCO's 2020 impact factor increased to 44.544, which is the highest among oncology publications and in the top 1️⃣% of all journals. fal.cn/3gsVk
  • user avatar
    No more reformatting! Submit your manuscript format-free to @ASCO Journals with EZSubmit ✅ fal.cn/3nubO
  • user avatar
    ☢️🦴 In a multi-center RCT ⚖️ (n=78), radiation to high-risk asymptomatic bone metastases ⬇️ skeletal-related events and prolonged overall survival in metastatic solid tumors: brnw.ch/21wE43a #radonc @ErinGillespieMD
  • user avatar
    ‼️ @ASCO Guideline just published: Treatment of Metastatic Colorectal Cancer Read in #JCO ➡️ fal.cn/3sOlo #crcsm #mCRC
  • user avatar
    #ASCOEdBook 📖 Editor in Chief @drdonsdizon invites you to access 🆕 2020 Ed Book articles for free at asco.org/edbook
    00:00
  • user avatar
    🍴 Olanzapine improved appetite and led to weight gain among patients with cancer undergoing #chemotherapy. #JCO #pallonc #supponc ➡️ fal.cn/3xhpC
  • user avatar
    Primary tumor resection followed by chemotherapy in patients with metastatic colorectal cancer doesn't improve survival over chemotherapy alone fal.cn/3dOjs @JCOG_official #crcsm #JCO
  • user avatar
    Breast cancer: 45 years of research & progress fal.cn/37KOd #bcsm #JCO
  • user avatar
    Patients with mismatch repair-deficient stomach cancer may not benefit from perioperative or adjuvant chemotherapy – results from 4 international randomised trials bit.ly/2mleOy7 #stcsm @CRUKCamAero
  • user avatar
    JCO 2018 Impact Factor has risen to 28.245, the highest in the history of the Journal bit.ly/2UKyfjh
  • user avatar
    We’re pleased to announce our new impact factor of 50.717‼️ Thank you to our authors and reviewers! #JCO #OncTwitter
  • user avatar
    Celebrating JCO's 40th: Congrats to the #1 most cited #JCO article of the past 40 years! 'Gemcitabine For Advanced Pancreas Cancer' by @BurrisSkip et al. (1997). Read the Flashback Foreword by @EileenMOReilly, Andrew L. Ko, MD, @DrJFriedberg 👉 brnw.ch/21wFmYc #OncTwitter